Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examini
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2084731" data-attributes="member: 124445"><p>SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and its partner Sigma-Tau S.p.A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN® (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza monovalent vaccine, Focetria™ from Novartis. According to investigators, ZADAXIN treatment given with the H1N1 vaccine led to a statistically significant (p value=0.04) increase in the percentage of subjects who seroconverted, also when evaluated 42 days after vaccination, compared to those who received the H1N1 vaccine alone... <a href="http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/SfqsDW0gqIk" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/SfqsDW0gqIk/3xmT" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2084731, member: 124445"] SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and its partner Sigma-Tau S.p.A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN® (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza monovalent vaccine, Focetria™ from Novartis. According to investigators, ZADAXIN treatment given with the H1N1 vaccine led to a statistically significant (p value=0.04) increase in the percentage of subjects who seroconverted, also when evaluated 42 days after vaccination, compared to those who received the H1N1 vaccine alone... [URL="http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/0/da"][IMG]http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/1/da"][IMG]http://feedads.g.doubleclick.net/~a/RITrFS8JWEFMBAVzKRlzkmoE80I/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/SfqsDW0gqIk[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/SfqsDW0gqIk/3xmT]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top